The page is the record's research on the issuer — no analyst, no rating, no view. # Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Tonix Pharmaceuticals Holding Corp. is listed on NASDAQ under ticker TNXP, ISIN US8902608392, LEI 529900ACPKP9QW20GX48. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Nevada. Segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 77 filings in the twelve months to 2026-11-08, across 53 filing days. The median gap between filing days is 5.5 days. The latest filing is a results filing dated 2026-10-15, 24 days before the record date. The NASDAQ median is 6.0 days for cadence, 52 filings and 5.0 days for latency. The 2834 Pharmaceutical Preparations sector median is 6.0 days for cadence, 63.0 filings and 4.0 days for latency. ## Auditor The auditor is not on the record, because the latest annual report cover carries no auditor name tag. The record holds one auditor change, dated 2026-03-18. The auditor's location is not on the record. ## Events and halts The record holds no listing, delisting or name change events. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as exchange tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names five research houses: TD Cowen, Raymond James, Alliance Global Partners, Canaccord Genuity and Zacks Small-Cap Research. ## Open research No openly published research notes are on the record. None was found. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed annual years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001430306.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/TNXP (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://ir.tonixpharma.com/stock-data/analyst-coverage (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/TNXP (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/TNXP · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp